Published through 2026-11-02 12:15 UTC · Automated cloud publishing.
Hoya Reports Stronger Overall Growth in Q2 2026, Contrasting with Earlier Health Care Segment Data
Understand the event
EyewearSearch News has received conflicting reports regarding Hoya Corporation’s financial performance for the second quarter of fiscal year 2026. An earlier report from Eyewear Intelligence, dated November 1, stated that revenues within the Health Care business segment—which encompasses eyeglass and contact lens activities—increased by 0.7 percent year-on-year to ¥120.0 billion. This initial data suggested a period of stability and marginal growth for Hoya's core lens operations. However, a newer report from Vision Monday, published on November 2, presents significantly different figures for the same reporting period. According to this latest account, Hoya reported a 10.9 percent year-over-year revenue increase to 260.2 billion yen for the quarter ended September 30, 2026. The report further notes that operating profit rose by 27 percent during this timeframe. While the Vision Monday article references the Life Care segment, it does not explicitly reconcile these higher aggregate figures with the previously cited Health Care segment data. Consequently, there is an unresolved discrepancy between the modest 0.7 percent growth attributed to the specific health care lens division and the robust 10.9 percent overall revenue growth reported in the subsequent update. Both sets of figures remain unverified against each other, leaving the precise contribution of the eyeglass and contact lens divisions to the total quarterly performance unclear.
AI-generated from reporting · updated 6 h ago
Reporting timeline
Follow the reporting for different perspectives.
- Vision Monday — BusinessHoya Reports Revenue Growth for Second Quarter and First Half of 2026
Hoya Corporation reported a 10.9 percent year-over-year revenue increase to 260.2 billion yen for the second quarter ended September 30, 2026, with operating profit rising 27 percent. The Life Care segment, which includes eyeglass and contact lenses, saw revenue grow 4.4 percent to over 153 billion yen. Eyeglass lens sales increased 8 percent (1 percent at constant currency), attributed to stable sales of high-value-added products such as MiYOSMART and foreign exchange effects, though U.S. eyeglass sales remained broadly flat due to restructuring. Contact lens sales via Eyecity stores rose 1 percent, supported by customer retention, private brand hoyaONE products, and subscription services. Intraocular lens sales grew 5 percent, driven by premium product demand in Europe and Japan. The Information Technology segment led overall growth with a 23.4 percent revenue increase. For the first half of 2026, total revenue reached 515.9 billion yen, up 13.4 percent.
- Eyewear IntelligenceHoya Reports 0.7% Growth in Q2 Health Care Lens Sales to ¥120.0 Billion
Hoya Corporation reported stability in its second quarter of fiscal year 2026 for the Health Care business, which includes eyeglass and contact lens activities. Divisional revenues increased by 0.7 percent year-on-year, reaching 120.0 billion Japanese yen (€682.1 million). The source title indicates that US sales fell while value-added products grew, though specific figures for these segments are not detailed in the provided text excerpt.
Event coverage trend
Current coverage 14·Comparable peak 16（11-2 14:00）·Comparable change over 24 hours –
Trends compare continuously observed participants only; coverage may be narrower than the current total. Point, click or use arrow keys to inspect hourly values.